Ironwood Pharmaceuticals Inc (IRWD) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 32.5% |
| Biotech & Pharma Sector Avg FCF Yield | 14.3% |
| Annual Free Cash Flow | $186M |
| Market Cap | $572M |
| P/E Ratio | 4.5x |
Ironwood Pharmaceuticals Inc's FCF yield of 32.5% is above the Biotech & Pharma sector average (14.3%).
Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc's (IRWD) free cash flow yield?
Ironwood Pharmaceuticals Inc's (IRWD) free cash flow yield is 32.5%. That is above the Biotech & Pharma sector average (14.3%).
Is IRWD's free cash flow yield good?
At 32.5%, IRWD's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Ironwood Pharmaceuticals Inc generate?
Ironwood Pharmaceuticals Inc generated $186M in free cash flow, against a market cap of $572M.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →